WWC
GOSS icon

Waypoint Wealth Counsel’s Gossamer Bio GOSS Stock Holding History

Waypoint Wealth Counsel’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-147
Closed -$10.7K – 102
2023
Q4 		$10.7K Buy
147
+4
+3% +$236 0.01% 98
2023
Q3 		$9.54K Buy
+143
New +$13.2K 0.01% 91

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Waypoint Wealth Counsel's GOSS Position: Q1 2024 in Review

Waypoint Wealth Counsel sold out of Gossamer Bio (GOSS) in Q1 2024, closing a stake of 147 shares — an estimated $10.7K sold.

Waypoint Wealth Counsel first reported a position in GOSS in Q3 2023 and held it in 2 quarters. The position peaked at $10.7K in Q4 2023. 108 funds tracked by Wall St. Rank hold GOSS as of Q1 2024.

  • Waypoint Wealth Counsel reported no remaining Gossamer Bio position as of Q1 2024 after selling out during the quarter.
  • Waypoint Wealth Counsel sold 147 Gossamer Bio shares in Q1 2024, an estimated $10.7K.
  • Waypoint Wealth Counsel first reported a position in Gossamer Bio in Q3 2023 and held it in 2 quarters.
  • Waypoint Wealth Counsel's Gossamer Bio position peaked at $10.7K in Q4 2023.
  • 108 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2024.

Based on Waypoint Wealth Counsel's 13F filing for Q1 2024, filed 12 Apr 2024.